Aequus Pharmaceuticals Inc. (TSXV:AQS)

Aequus Pharmaceuticals Revenue

Aequus Pharmaceuticals had revenue of 251.75K CAD in the quarter ending September 30, 2025, with 69.74% growth. This brings the company's revenue in the last twelve months to 918.47K, up 122.30% year-over-year. In the year 2024, Aequus Pharmaceuticals had annual revenue of 584.24K with 129.21% growth.

• Revenue (ttm): 918.47K
• Revenue Growth: +122.30%
• P/S Ratio: 0.72
• Revenue / Employee: n/a
• Employees: 12
• Market Cap: 663.17K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	584.24K	329.34K	129.21%
Dec 31, 2023	254.90K	-1.12M	-81.53%
Dec 31, 2022	1.38M	-1.33M	-49.17%
Dec 31, 2021	2.71M	122.09K	4.71%
Dec 31, 2020	2.59M	960.09K	58.81%